|
Published: November 16, 2024
Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
American Heart Association Scientific Sessions 2024, Abstract 4171195
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.